Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Revenue (2016 - 2025)

Historic Revenue for Wave Life Sciences (WVE) over the last 11 years, with Q2 2025 value amounting to $8.7 million.

  • Wave Life Sciences' Revenue fell 5582.47% to $8.7 million in Q2 2025 from the same period last year, while for Sep 2025 it was $17.9 million, marking a year-over-year decrease of 7083.51%. This contributed to the annual value of $108.3 million for FY2024, which is 441.55% down from last year.
  • Latest data reveals that Wave Life Sciences reported Revenue of $8.7 million as of Q2 2025, which was down 5582.47% from $9.2 million recorded in Q1 2025.
  • Wave Life Sciences' 5-year Revenue high stood at $49.2 million for Q3 2023, and its period low was $285000.0 during Q3 2022.
  • In the last 5 years, Wave Life Sciences' Revenue had a median value of $9.2 million in 2025 and averaged $13.9 million.
  • Its Revenue has fluctuated over the past 5 years, first crashed by 9921.75% in 2022, then skyrocketed by 1716807.02% in 2023.
  • Over the past 5 years, Wave Life Sciences' Revenue (Quarter) stood at $1.8 million in 2021, then fell by 29.8% to $1.2 million in 2022, then skyrocketed by 2245.12% to $29.1 million in 2023, then plummeted by 32.23% to $19.7 million in 2024, then plummeted by 55.82% to $8.7 million in 2025.
  • Its Revenue stands at $8.7 million for Q2 2025, versus $9.2 million for Q1 2025 and $19.7 million for Q2 2024.